Unlike testosterone therapy, estrogen therapy, growth hormone therapy, or other hormone-based treatments, BPC-157 is generally not considered a hormone replacement treatment
The beneficial effect of BPC 157 on Parkinson's disease in rats
The peptide accelerates regeneration of intestinal mucosa and submucosa, restores tight junction proteins (claudin-1, occludin, ZO-1) that fail in intestinal permeability syndromes, and increases local blood supply through VEGF-mediated angiogenesis
Participants received one oral tablet containing 1000 g of cyanocobalamin (HealthAid, Co, UK) or a placebo (Barij Essence Co, Kashan, Iran) daily for 12 weeks
Sublingual methylcobalamin treatment is as effective as intramuscular and peroral cyanocobalamin in children age 03 years